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Abstract The contribution of entire domains or particular
amino acid residues of the phenylalanyl-tRNA synthetase (FRS)
from Thermus thermophilus to the interaction with tRNAPhe was
studied. Removal of domain 8 of the L subunit resulted in drastic
reduction of the dissociation constant of the FRSWtRNAPhe
complex. Neither the removal of arginine 2 of the L subunit,
which makes the only major contact between domains L1^5 and
the tRNA, nor the replacement of the conserved proline 473 by
glycine had an influence on the aminoacylation activity of the
FRS. Thus, the body comprising domains 1^5 of the L subunit
may not be essential for efficient aminoacylation of tRNAPhe by
the FRS and rather be involved in other functions.
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1. Introduction
The phenylalanyl-tRNA synthetase (FRS) belongs to class
II of aminoacyl-tRNA synthetases (aaRSs) [1]. With the ex-
ception of the monomeric yeast mitochondrial FRS, all other
known FRSs have a heterotetrameric quaternary structure
resembling a functionally dimeric (KL)2 enzyme [2]. The K
subunits comprise the catalytic aminoacylation site with the
three sequence motifs characteristic for class II aaRSs. In
addition a N-terminal domain composed of two long antipar-
allel K helices stabilizes the binding of the tRNAPhe to the
enzyme [3]. The L subunits exhibit a complicated modular
arrangement of as many as eight di¡erent domains. Two of
them have typical helix-loop-helix motifs (domains L1 and 5)
and may be responsible for the speci¢c interaction of the FRS
with DNA sequences (manuscript submitted). Another do-
main (L6) structurally resembles the catalytic domain of the
K subunit. The function of this pseudocatalytic domain, how-
ever, is obscure. Domain L3, whose function is also unknown,
is structurally similar to the Scr homology 3 (SH3) domain of
eukaryotic tyrosine kinases. It is, therefore, an open question
how many and which domains of the FRS are absolutely
required for the aminoacylation of tRNAPhe. Other functions
accomplished by particular domains of this enzyme should be
considered as well.
The anticodon of tRNAPhe is one of the major recognition
elements for the FRS [4^6]. Two domains of the L subunit
were good candidates to accomplish this anticodon recogni-
tion, i.e. domain L2, which structurally resembles the antico-
don binding domain of the bacterial aspartyl-tRNA synthe-
tase, and domain L8, which is similar to the RNA binding
domain of the spliceosomal protein U1A. The results of our
previously reported footprinting experiments of tRNAPhe
transcripts with the FRS suggested an orientation of the
tRNAPhe with the anticodon pointing towards domain L8
rather than domain L2 [7].
In this work we report that domain L8 is essential for ami-
noacylation. Furthermore we provide evidence that several
domains of the L subunit are dispensable for aminoacylation.
Thus, our experimentally obtained biochemical results on the
FRS-tRNAPhe interaction complete the recently published
structural data of the FRSWtRNAPhe complex [3].
2. Materials and methods
2.1. Bacterial strains, plasmids, recombinant DNA technology and
overexpression
Escherichia coli strain SG13009 [8] was grown in Luria-Bertani (LB)
nutrient medium [9] as previously reported [10]. For deletion muta-
genesis of pheT the plasmid pPheST1 [11] was hydrolyzed with PstI
and NotI, whose cleavage sites are located downstream of the pheT
gene, thus enabling the unidirectional deletion of the 3P portion of
pheT by the exonuclease III/nuclease S1 technique (Fig. 1). The ex-
tents of the deletions were mapped by restriction analyses of the
resulting plasmids (expressing FRSLv759^785 and FRSLv742^785)
with suitable combinations of endonucleases. The exact end points
of the deletions were determined by DNA sequencing. For site-di-
rected mutagenesis [12] and expression the plasmid pALPheST20
[10] based on the vector pKKM13+ [13] was used with oligodeoxyri-
bonucleotides 5P-GGAGAAGGGCAC-CATAGAACCCCCT for
FRSLvR2, 5P-TCTTGGAAGGCGAGTTATTTGTCCGGGAGG
for FRSLv681^785, and 5P-GCGGGGAGGGCCAAACCGATGGT-
CTCGTAGC for FRSLP473G. Standard recombinant DNA methods
were performed according to the protocols of Ausubel et al. [14] and
Sambrook et al. [15].
2.2. Enzyme puri¢cation and characterization
The FRS variants were puri¢ed as described for the native FRS
[10]. The molecular masses of the FRS and its variants were deter-
mined by size exclusion chromatography as previously reported [16].
The thermal stability of the proteins was assessed by their temper-
ature-dependent change in UV absorbance using 0.5 WM protein sol-
utions [16].
The aminoacylation activity of the FRS and its variants was deter-
mined by a ¢lter binding assay in a total volume of 60 Wl of 100 mM
sodium cacodylate, pH 7.6, 10 mM KCl, 8 mM MgSO4, 5 mM 2-
mercaptoethanol, 2 mM ATP, 20 WM [14C]phenylalanine (50 Ci/mol)
and 2 WM puri¢ed T. thermophilus tRNAPhe (overproduced in E. coli ;
aminoacylation capacity 1580 pmol phenylalanine/A260 tRNAPhe) at
65‡C. The reaction was started by the addition of 1^8 nM FRS.
Aliquots of 10 Wl were withdrawn at 30, 60, 90, 120, and 150 s,
pipetted on Whatman 3MM papers, and the aminoacylated tRNA
was precipitated in 10% trichloroacetic acid. The ¢lter-bound radio-
activity, after washing twice with 10% trichloroacetic acid and once
with ethanol, was counted. The protein concentration was determined
by the Bio-Rad (Hercules, CA, USA) assay. One unit of FRS activity
was de¢ned as the amount of enzyme needed to attach 1 nmol of
[14C]phenylalanine to the tRNA in 1 min.
For the determination of kinetic data, the active sites were titrated
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according to Fersht et al. [17]. The concentration of the substrate
[14C]phenylalanine (125 Ci/mol) was varied in the range of 2^14
WM. When the dependence of the substrate tRNAPhe was investigated,
its concentration was varied in the range of 0.1^1 WM. The data were
analyzed using Eadie-Hofstee and Lineweaver-Burk plots [18].
The formation of the phenylalanyladenylate was tested by the de-
termination of radioactively labeled ATP in the equilibrium of an
exchange reaction with [32P]pyrophosphate, non-labeled ATP, and
phenylalanine as substrates [19]. In a total volume of 300 Wl contain-
ing 100 mM Tris, pH 7.6, 10 mM MgCl2, 2 mM ATP, 2 mM KF,
2 mM [32P]pyrophosphate (0.5 Ci/mol), and 2 mM phenylalanine the
reaction was started with 8^40 nM of the FRS or its variants. Ali-
quots of 40 Wl were drawn after 2, 4, 6, 8, 12, and 15 min of incuba-
tion at 50‡C and immediately mixed with 70 Wl of 12% perchloric acid
and 300 mM pyrophosphate. 100 Wl of the solution was ¢ltered
through charcoal ¢lters (Schleicher p Schuºll, Germany), the ¢lters
were rinsed with 5 ml water and 5 ml ethanol, dried, and the radio-
activity was counted.
For the determination of kinetic data in dependence of the sub-
strate phenylalanine its concentration was varied in the range of 2^
12 WM. When the dependence of the substrate ATP was investigated,
its concentration was varied in the range of 0.5^8 mM. The data were
analyzed using Eadie-Hofstee and Lineweaver-Burk plots [18].
2.3. Determination of tRNAPhe transcript binding by the FRS
K[32P]GTP (3000 Ci/mmol)-labeled T7 RNA polymerase transcripts
[20] of T. thermophilus tRNAPhe were obtained as previously de-
scribed [7] using plasmid pT7TthF-5 (P. Ho¡muºller, unpublished),
which contains the pheU gene from T. thermophilus [21] linked to a
T7 promoter in pUC19 [22].
To determine the approximate binding constant, in a ¢lter binding
assay [14] 2 nM tRNAPhe transcript in 20 mM Tris, pH 7.5, 50 mM
KCl, 10 mM MgCl2, 0.1 mM DTT, 0.1 mM PMSF, and 5% glycerol
were mixed with 50 fM^10 WM FRS in a total volume of 400 Wl and
incubated for 15 min at 40‡C. The solution was ¢ltered through nitro-
cellulose ¢lters (Schleicher p Schuºll, Germany), washed with 400 Wl of
bu¡er, dried, and the radioactivity was counted.
3. Results and discussion
3.1. Involvement of the C-terminal domain 8 of the FRS L
subunit in tRNAPhe binding
To determine the possible involvement of the C-terminal
domain 8 of the FRS L subunit in tRNA binding, a series
of mutants with deletions in the corresponding 3P portion of
the pheT gene were constructed. Based on the three-dimen-
sional structure of the FRS [2] an additional FRS variant
completely lacking the entire domain 8 was constructed by
site-directed mutagenesis. This was accomplished by the intro-
duction of a stop codon in the pheT gene yielding in this way
the FRS variant FRSLv681^785 with their L subunits consist-
ing of only 680 N-terminal amino acids. All FRS variants
were overproduced in E. coli, puri¢ed and checked for their
ability to form phenylalanyladenylate and to aminoacylate
tRNAPhe (Fig. 1). Adenylate formation was a¡ected by
none of the variants. Aminoacylation of tRNAPhe still oc-
curred when the 27 C-terminal amino acids were missing (var-
iant FRSLv759^785). However, the removal of 44 C-terminal
amino acids (variant FRSLv742^785) or the whole domain 8
(variant FRSLv681^785) resulted in the complete loss of ami-
noacylation activity. By size exclusion chromatography the
molecular mass of variant FRSLv681^785, which lacks do-
main 8, was demonstrated to correspond to the heterote-
tramer (data not shown). Though thermal denaturation of
this variant occurred at a slightly lower temperature than
that of the wild-type FRS (6 5‡C; Fig. 2), we suppose that
the removal of domain 8 had no major e¡ect on the overall
structure of the remaining protein. This was also con¢rmed by
the KM and kcat values for the two substrates phenylalanine
and ATP determined by the pyrophosphate exchange reac-
tion, which are in the same range as those of the intact
FRS (Table 1). This indicates that the catalytic center was
not a¡ected by the truncation. However, the a⁄nity of
tRNAPhe transcripts to this variant was drastically reduced
(Fig. 3). The apparent dissociation constant determined by a
¢lter binding assay was, compared to the wild-type FRS,
about three orders of magnitude lower, which is at the level
of unspeci¢c binding. It thus can be concluded that the inac-
tivity in aminoacylation of this variant was due to the weak
and uncoordinated binding of the tRNAPhe to the enzyme.
This further implies that the C-terminal domain 8 is respon-
sible for the interaction with the anticodon as the major de-
terminant of tRNAPhe, which is con¢rmed by the X-ray struc-
ture of the FRSWtRNAPhe complex [3]. Anticodon base-speci¢c
interactions occur via hydrogen bonds with aspartates 696
and 729, serine 742 and arginine 780, by hydrophobic inter-
actions with tyrosine 731 and by van der Waals contacts with
leucine 697 and alanine 698. Upon the removal of 44 C-ter-
minal amino acids, some of these important amino acids are
missing in variant FRSLv742^785. Moreover, the architecture
of the whole domain was probably destroyed, which explains
the inability of this truncated protein to aminoacylate
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Fig. 1. E¡ect of truncation of the C-terminal portion of the FRS L subunit. At the upper left panel the extensions of the FRS-encoding genes
pheST with respect to the restriction map of the overexpressing plasmid are shown. The wild-type gene and the extents of three di¡erent gene
deletions are indicated by the gaps in the bold lines below. The positions of missing and the number of removed amino acids (aa) are denoted
above these lines and in the gaps, respectively. In the right panel the qualitative properties of the corresponding FRS variants are indicated: +,
property detectable; 3, property not detectable; nd, not determined.
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tRNAPhe. Surprisingly, the removal of 27 C-terminal amino
acids, corresponding to an K helix and the adjacent C-termi-
nal arm of domain 8, did not abolish aminoacylation activity.
This indicates that the domain was not destroyed by this
truncation and tRNA still can e⁄ciently be bound to the
FRS variant. Possibly the speci¢city of the anticodon recog-
nition may be a¡ected.
3.2. Domains 1^5 of the FRS L subunit may be dispensable
for tRNAPhe aminoacylation
Since the acceptor domain of tRNAPhe interacts with the K
subunit and the anticodon is bound by domain 8 of the L
subunit, it was questionable whether the whole body compris-
ing domains 1^5 of the L subunit makes a contribution to the
interaction with tRNAPhe. Several lysine residues (2, 60, 106)
in domains 1 and 2 of the E. coli FRS were reported to be
labeled with periodate-oxidized tRNAPhe [23,24]. This led to
the conclusion that these domains are in close contact with the
acceptor end of the tRNA. However, in the three-dimensional
structure of the T. thermophilus FRSWtRNAPhe complex only
the side chain of arginine 2 corresponding to lysine 2 in the E.
coli enzyme was found to form salt bridges with the sugar-
phosphate backbone of the acceptor helix at A73 and C74 [3].
No other contacts exist between domains 1^5 and tRNAPhe,
apart from two putative hydrogen bonds. Since genetically
produced FRS variants with a truncated N-terminus of the
L subunit were unstable and could not be studied, we con-
structed a variant just lacking arginine 2. Neither the amino-
acylation activity nor the catalytic e⁄ciency of this variant
(FRSLvR2) was substantially a¡ected (Table 1). This indi-
cates that the presence of a basic residue at this position is
not an absolute requirement for the e⁄cient aminoacylation
of tRNAPhe, as also re£ected by the non-conservation of this
residue among the FRSs from di¡erent species. Interestingly,
the variant FRSLvR2 exhibited higher thermal stability with
di¡erent denaturation kinetics compared to the wild-type FRS
(Fig. 2).
Domains 1^5 of the L subunit form a body which is spa-
tially apart from the rest of the FRS molecule. In the short
linker between domains 5 and 6 a proline is remarkable (po-
sition 473), which is conserved among the FRSs from di¡erent
organisms. Due to the restricted rotation angles this proline
may be involved in the positioning of the body comprising
domains 1^5 with respect to the remainder of the molecule.
To study the possible importance of such a ¢xed body for the
stabilization of the tRNA we replaced the proline by a £exible
glycine (FRSLP473G). However, neither aminoacylation ac-
tivity nor catalytic e⁄ciency of this variant was signi¢cantly
a¡ected (Table 1). This is in agreement with structural data of
the FRSWtRNAPhe complex, where, in contrast to other do-
mains of the molecule, no major movement of domains 1^5
upon binding of the tRNAPhe occurs compared to the free
state of the FRS. The conservation of this proline residue
may be important for an additional function of the FRS
(see below), e.g. the correct positioning of the two symmetri-
cally arranged helix-loop-helix motifs located in domains 5 of
the functionally dimeric FRS [2].
In conclusion, there is no evidence that the body comprising
domains 1^5 of the L subunit is required for the e⁄cient
aminoacylation of tRNAPhe by the FRS. The few contacts
reported between domains 1^5 and tRNAPhe may be not es-
sential [3]. This is in agreement with the composition of the
yeast mitochondrial FRS, which lacks the domain L1 and L3^
7 but is fully active in aminoacylation. The part of the mol-
ecule comprising domains 1^5 of the other FRSs may also be
involved in a function not related to aminoacylation, which is
not relevant in mitochondria. We have clear evidence that the
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Table 1
Catalytic constants of the FRS and its variants for aminoacylation and ATP-[32P]PPi exchange with tRNAPhe, phenylalanine and ATP as sub-
strates
Aminoacylation ATP-[32P]PPi exchange
tRNAPhe Phenylalanine Phenylalanine ATP
KM
(WM)
kcat/KM
(105 s31 M31)
KM
(WM)
kcat/KM
(105 s31 M31)
kcat
(s31)
KM
(WM)
kcat/KM
(105 s31 M31)
KM
(WM)
kcat/KM
(105 s31 M31)
kcat
(s31)
FRS 0.32 12.6 2.1 1.9 0.40 3.57 146.6 1080 0.48 52.35
FRSLv681^785 na na na na na 1.87 308.8 1589 0.36 57.75
FRSLvR2 0.40 10.6 2.3 1.8 0.42 nd nd nd nd nd
FRSLP473G 0.35 10.1 2.1 1.7 0.35 nd nd nd nd nd
na, not applicable; nd, not determined.
Fig. 3. Binding of the tRNAPhe to the FRS (b) and a FRS variant
lacking domain 8 (FRSLv681^785) of the L subunit (E) determined
in a ¢lter binding assay by titration of increasing protein concentra-
tions to the tRNAPhe. The turning points of the curves indicate the
approximate dissociation constants.
Fig. 2. Thermal stability of the FRS (b), FRSLvR2 (R) and
FRSLv681^785 (E) determined by the change of UV absorance in
dependence on the temperature.
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FRS from T. thermophilus speci¢cally binds DNA (to be pub-
lished elsewhere). Since the enhanced expression of one hu-
man FRS subunit seems causally be related to tumorigenic
myeloid leukemia [25], it is a tantalising assumption that the
FRS, apart from its aminoacylation activity, interferes with a
fundamental process of cell proliferation which is related in
bacteria and in humans, e.g. by the regulatory action involv-
ing its domains L1^5.
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